Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33

Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33–35weeks

Published:2012-11 Issue:6 Volume:33 Page:1287-1292
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Blanken Maarten,Rovers Maroeska,Sanders Elisabeth,Bont Louis

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference25 articles.

1. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

2. Bronchiolitis;Smyth;Lancet,2006

3. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial;Ermers;BMJ,2009

4. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis;Bont;Intensive Care Med,2002

5. Risk factors for mechanical ventilation in respiratory syncytial virus infection;Tissing;Eur J Pediatr,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-IL-5 therapies for asthma;Cochrane Database of Systematic Reviews;2022-07-12

2. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children;Cochrane Database of Systematic Reviews;2021-11-16

3. Anti-IL5 therapies for asthma;Cochrane Database of Systematic Reviews;2017-09-21

4. Mepolizumab versus placebo for asthma;Cochrane Database of Systematic Reviews;2015-07-27

5. Palivizumab (Synagis®);Handbook of Therapeutic Antibodies;2014-08-12